BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SciLifeLab - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SciLifeLab
X-ORIGINAL-URL:https://www.scilifelab.se
X-WR-CALDESC:Events for SciLifeLab
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20231107T130000
DTEND;TZID=Europe/Stockholm:20231107T140000
DTSTAMP:20260525T063657
CREATED:20231030T125153Z
LAST-MODIFIED:20231030T132952Z
UID:157963-1699362000-1699365600@www.scilifelab.se
SUMMARY:Discovery of SARS-CoV-2 Main Protease inhibitors at the DDD platform
DESCRIPTION:Pandemic preparedness and the generation of SARS-CoV-2 inhibitors – A new exit from SciLifeLab Drug Discovery and Development platform \n\n\n\nDDD Exit Event 2023-11-07\, zoomcast 13.00 \n\n\n\n \n\n\n\nPresenters\n\n\n\nDr. Ulf Ribacke. Dept. of Microbiology\, Tumor and Cell Biology\, Karolinska InstitutetTel: +46 70 497 5196\, Email: ulf.ribacke@ki.se \n\n\n\nProf. Jens Carlsson\, Dept. of Cell and Molecular Biology\, Uppsala UniversityTel: +46 72 227 7976\, Email: jens.carlsson@icm.uu.se \n\n\n\nAbstract\n\n\n\nSciLifeLab has been commissioned by the government to build laboratory capacity to assist in future pandemics through research and competence and technology development. Hear more about the SciLifeLab Pandemic Laboratory Preparedness program from Ulf Ribacke\, (SciLifeLab and Karolinska Institutet) and groundbreaking research performed by researchers at Uppsala University that led to discovery of potent main protease SARS-CoV-2 inhibitors. \n\n\n\nJens Carlsson\, Helena Danielson\, Anja Sandström and Lindon Moodie have recently signed an agreement for international partnering of a project focusing on development of drugs for treatment of COVID-19 (DP_JC_188). \n\n\n\nThe project was funded by the National COVID-19 Research Program initiated by the Knut and Alice Wallenberg Foundation. Hit compounds identified by virtual screening were published in 2022 by Luttens et al. (https://doi.org/10.1021/jacs.1c08402). Hit-to-lead generation was then performed together with the Drug Discovery and Development Platform in the DP_JC_188 project. Lead optimization and preclinical development of assets are now supported by an international pharmaceutical company. \n\n\n\nShort speakers biography:\n\n\n\nUlf Ribacke: Ulf is scientific co-director of the SciLifeLab Pandemic Laboratory Preparedness program and heads two research labs located at Karolinska Institutet and Uppsala University\, both dedicated to resolve how malaria parasites adapt to evade cellular stress with the ultimate goal to identify targets for new interventions. \n\n\n\nJens Carlsson: Jens is a Professor of Computational Biochemistry at Uppsala University\, where his group uses computational models to understand protein function at the molecular level and develops strategies for drug discovery.For more information\, visit http://www.carlssonlab.org/. \n\n\n\nUlf RibackeKarolinska InstitutetScientific Lead – Pandemic Laboratory Preparedness at SciLifeLabulf.ribacke@ki.se\n\n\n\nJens CarlssonUppsala Universityjens.carlsson@icm.uu.se
URL:https://www.scilifelab.se/event/discovery-of-sars-cov2-mpro-inhibitors-at-the-ddd-platform/
CATEGORIES:Event
END:VEVENT
END:VCALENDAR